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Abstract: Omega-3 polyunsaturated fatty acids (n-3 PUFA) are termed essential fatty acids
because they cannot be synthesized de novo by humans due to the lack of delta-12 and delta-15
desaturase enzymes and must therefore be acquired from the diet. n-3 PUFA include α-linolenic
acid (ALA, 18:3n-3), eicosapentaenoic (EPA, 20:5n-3), docosahexaenoic (DHA, 22:6n-3), and the
less recognized docosapentaenoic acid (DPA, 22:5n-3). The three long-chain (≥C20) n-3 PUFA
(n-3 LC-PUFA), EPA, DHA, and DPA play an important role in human health by reducing the risk of
chronic diseases. Up to the present time, seafood, and in particular, fish oil-derived products, have
been the richest sources of n-3 LC-PUFA. The human diet generally contains insufficient amounts of
these essential FA due largely to the low consumption of seafood. This issue provides opportunities
to enrich the content of n-3 PUFA in other common food groups. Milk and milk products have
traditionally been a major component of human diets, but are also among some of the poorest sources
of n-3 PUFA. Consideration of the high consumption of milk and its processed products worldwide
and the human health benefits has led to a large number of studies targeting the enhancement of
n-3 PUFA content in dairy products. The main objective of this review was to evaluate the major
strategies that have been employed to enhance n-3 PUFA content in dairy products and to unravel
potential knowledge gaps for further research on this topic. Nutritional manipulation to date has been
the main approach for altering milk fatty acids (FA) in ruminants. However, the main challenge is
ruminal biohydrogenation in which dietary PUFA are hydrogenated into monounsaturated FA and/or
ultimately, saturated FA, due to rumen microbial activities. The inclusion of oil seed and vegetable
oil in dairy animal diets significantly elevates ALA content, while the addition of rumen-protected
marine-derived supplements is the most effective way to increase the concentration of EPA, DHA,
and DPA in dairy products. In our view, the mechanisms of n-3 LC-PUFA biosynthesis pathway from
ALA and the biohydrogenation of individual n-3 LC-PUFA in ruminants need to be better elucidated.
Identified knowledge gaps regarding the activities of candidate genes regulating the concentrations
of n-3 PUFA and the responses of ruminants to specific lipid supplementation regimes are also critical
to a greater understanding of nutrition-genetics interactions driving lipid metabolism.
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1. Introduction
Omega-3 polyunsaturated fatty acids (n-3 PUFA) contain more than two double bonds with the first
double bond on the third carbon atom from the methyl end of the molecule. The common types of n-3
PUFA are: Shorter chain (SC, ≤C18) n-3 PUFA including α-linolenic acid (ALA, 18:3n-3) and stearidonic
acid (SDA, 18:4n-3), and long-chain (≥C20) n-3 PUFA (n-3 LC-PUFA) including eicosapentaenoic
(EPA, 20:5n-3); docosahexaenoic (DHA, 22:6n-3); and the less studied docosapentaenoic (DPA, 22:5n-3)
acids [1]. The focus herein is on LC-PUFA due to their beneficial effects in human pathologies.
Since Bang et al. [2] first demonstrated the positive relationship between low amounts of some
non-communicable diseases and high n-3 LC-PUFA consumption of the Eskimos, numerous
studies have consistently demonstrated their vital role in inhibiting major chronic diseases [3],
including adipogenic, diabetogenic, atherogenic [4], inflammatory [5,6] and carcinogenic [7,8] diseases.
Moreover, high consumption of n-3 LC-PUFA is typically associated with a higher cognitive performance
and a lower risk of developing Alzheimer’s disease [9–11]. Previous studies on n-3 LC-PUFA have
focused mainly on EPA and DHA, but not DPA despite its structural and beneficial effects on human
health being similar to those of EPA and DHA [12]. The unavailability of pure DPA as a commercial
product for performing clinical and nutritional trials is one possible explanation for this shortcoming.
The term n-3 LC-PUFA in this current review includes EPA, DHA, and DPA.
Chronic or non-communicable diseases have remained as the most leading cause of death
worldwide, with 41 million deaths accounting for 71% of reported global deaths (57 million) [13].
This report also indicated that an unhealthy diet with low intake of n-3 LC-PUFA, continues to be one
of the main factors that either directly or indirectly induce chronic diseases. Although there is a general
awareness that fish and seafood are the dominant source of n-3 LC-PUFA, seafood consumption is still
insufficient, thus the human diet persists with low n-3 PUFA intake [14]. The traditional diet often does
not contain regular consumption of fish and marine products, especially in Western countries [12,15].
When taken together with the often high cost of seafood [16], these combined factors probably have
been the major grounds for this trend. In contrast, milk and its processed products are known as
poor sources of n-3 LC-PUFA content [17], although they have played an important role in human
diets for more than 8000 years [18]. This is because dairy foods are important sources of energy,
protein, fat, and vital microelements including calcium, vitamin D and potassium for humans [19,20].
According to the OECD/FAO report [21], the 2015 global consumption of milk and dairy products
was 111.3 kg per capita, and is expected to increase by approximately 12.5% by 2025. This fact has
led to a number of studies focusing on enhancing the beneficial n-3 PUFA and n-3 LC-PUFA in milk
and its processed products, mostly from cows and sheep, for human consumption [17]. The aim of
the present review was, therefore, to evaluate and update the published literature on the effects of
n-3 LC-PUFA on human health and to also examine recent research on improving the concentrations
of these health beneficial FA in dairy-derived foods. Consequently, outcomes from this review may
open up opportunities for future further research into nutrition-genetics interactions influencing lipid
metabolism in dairy-derived foods.
2. Metabolic Pathways, Human Health Benefits and Recommended Intake of n-3 PUFA
2.1. Dietary n-3 PUFA Intake Recommendations
Dietary intake recommendations of n-3 LC-PUFA from different organizations vary largely and
also depend on many factors including age, gender, and consumption purposes of consumers [1,22].
Adhering to National Health and Medical Research Council (NHMRC) recommendations [23], the daily
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intakes of ALA and total EPA+DPA+DHA considered adequate for men are 1.3 g/day, and 160 mg/day,
and for women, 0.8 g/day and 90 mg/day, respectively. These dietary requirements of n-3 PUFA are
not optimal, but are seen as sufficient to prevent deficiency symptoms for adults. However, with the
aim at reducing chronic disease risk, the NHMRC suggested that dietary intakes of total n-3 LC-PUFA
of 430 mg/day for women, and 610 mg/day for men should be adequate to meet requirement levels.
In order to prevent the risk of coronary heart disease, FAO and WHO [24] recommended sufficient
daily intake of EPA + DHA at 250 mg for adult males and non-pregnant or/and non-lactating adult
females, and at 300 mg for lactating and pregnant women. In the case of disease treatment, such as for
hypertriglyceridemia patients who have high triglyceride level symptoms, a much higher intake of
total EPA + DHA from 2–4 g/day is recommended by the American Heart Association [25]. A recent
review by Nguyen et al. [22] stated that the intake recommendation of n-3 LC-PUFA for primary
prevention of cardiovascular disease across all organizations is about 500 mg/day, which is equivalent
to two or three servings of fish per week.
2.2. Metabolic Pathways for the Biosynthesis and Dietary Sources of n-3 PUFA
Due to the lack of delta-12 and delta-15 desaturase enzymes, mammals (including humans)
cannot synthesize n-3 PUFA de novo, thus these essential FA must be acquired via foods or nutritional
supplements [26]. The first step in the n-3 LC-PUFA synthesis pathway for the human body is the
conversion of ALA to SDA, with ALA mostly acquired from green plant tissues and plant-derived oils,
especially flaxseed/linseed and canola oil [27] (Table 1).
Table 1. Common food sources of ALA (18:3n-3, as gram per serving).
Item Unit ALA
Flaxseed oil g/tbsp 7.26
Chia seed g/ounce 5.06
English walnuts g/ounce 2.57
Whole flaxseed g/tbsp 2.35
Canola oil g/tbsp 1.28
Soybean oil g/tbsp 0.92
Black walnut g/ounce 0.76
Data from Office of Dietary Supplements, National Institute of Health (NIH) [28]. Tbsp denotes tablespoon.
There are two recognised biosynthesis pathways for n-3 LC-PUFA (Figure 1), including the
presently accepted pathway [29] and conventional metabolic pathway [30]. In the former pathway,
DHA was produced from DPA via sequential desaturation and elongation combined with a final
β-oxidation where tetracosapentaenoic acid (24:5n-3) is chain-shortened by two carbons. The latter
conventional metabolic pathway, in contrast, consists of direct conversion of DHA from DPA under
the catalysis of delta-4 desaturase enzyme. The molecular evidence for delta-4 desaturase that
supported the conventional metabolic pathway for n-3 LC-PUFA biosynthesis was first demonstrated
by Park et al. [31]. Further research is needed to clarify the specific pathway for n-3 LC-PUFA
biosynthesis in the human body, but most studies have confirmed a very low rate of conversion of
ALA to n-3 LC-PUFA, in particular, to DHA (0.05% or less) [32]. The specific mechanism(s) by which
biosynthesis of these essential FA occurs is limited in man and is still largely unknown. Calder [3]
suggested that a possible cause for this limitation is the competition between biosynthetic pathways of
ALA conversion to n-3 LC-PUFA and linoleic acid (18:2n-6) conversion to n-6 LC-PUFA as the two
pathways employ the same set of enzymes. In addition, based on previous animal studies, deficiencies
of insulin [33], protein [34] and microminerals [35] might lead to lower delta-6 desaturase enzyme
activity, thus contributing to the low efficiency of this pathway.
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Figure 1. Possible biosynthesis and metabolic pathway of n-3 LC-PUFA. Thick arrows represent the
conventional pathway; dotted lines with arrows represent presently accepted pathway (adapted from
Park et al. [30] and Sprecher [29]).
Due to the limitation of n-3 LC-PUFA biosynthesis in the human body from ALA, the best way
of acquiring these essential FA is from dietary sources [36]. Fish and seafood currently are the major
sources of n-3 LC-PUFA with high concentration ranges across seafood species [1,37]. The average
content of total n-3 LC-PUFA in 150 g wet weight of wild caught Australian fish, shellfish, prawns,
and lobsters are 350, 250, 180, and 160 mg respectively, with a range of species also having markedly
higher contents than these average values [1]. The level of these FA for the two common fish species
farmed in Australia - Atlantic salmon, and barramundi - examined by Nichols et al. [38] are 980 and
790 mg/100 g, respectively. Compared to the previous results [1], the concentration of n-3 LC-PUFA for
these farmed fish had decreased significantly by 50% or more. Changes in feed ingredients for farmed
fish, in which fish meal and fish oils have been substituted by non-traditional oil sources such as plant
and/or chicken oils were the reasons for this trend [38]. Foods derived from animals have much lower
n-3 LC-PUFA content in comparison to marine products (Table 2).
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Table 2. Content of n-3 LC-PUFA in common seafood and other animal sources.
Item Unit EPA DHA DPA Total n-3 LC-PUFA Reference
Wild seafood Nichols et al. [1]
Fish mg/150 g - - - 350
Shellfish mg/150 g - - - 225
Prawns mg/150 g - - - 180
Lobster mg/150 g - - - 160
Farmed fish
Atlantic salmon mg/100 g - - - 980 Nichols et al. [38]
Barramundi mg/100 g - - - 790
Other animal sources
Beef mg/100 g 15 12 20 47 Garcia et al. [39]
Chicken breast mg/100 g - - - 62.04 Konieczka et al. [40]
Pork mg/100 g 23.3 3.9 21.1 48.3 Dugan et al. [41]
Feedlot lamb meat mg/100 g 17.9 4.9 15.6 38.4 Nguyen et al. [42]
28.9 13.3 19.6 61.8 Le et al. [43]
Grazing lamb meat mg/100 g 25 7.1 23.7 55.8 Le et al. [44]
Sheep milk mg/250 mL 17.8 19.8 24.1 61.7 Nguyen et al. [45]
Sheep cheese mg/40 g 14.3 12.8 17.1 44.2 Nguyen et al. [46]
Cow milk mg/100 g 3.3 - 4.4 - Benbrook et al. [47]
2.3. n-3 LC-PUFA Consumption and Chronic Diseases
The biological functions of n-3 LC-PUFA are firstly represented by their occurrence in all cellular
membranes in all tissues of the body, and in particular, at high content levels in the retina, brain,
and myocardium [48,49]. For example, due to a high concentration of DHA in the membranes of the
human retina and brain, it plays an important role in regulating membrane receptors, membrane-bound
enzymes and transduction signals [48]. In addition, n-3 LC-PUFA have the potential to transform
into a group of mediators such as the E-series and D-series resolvins at the expense of inflammation
mediators from arachidonic acid (20:4n-6, ARA) which is the primary cause of various chronic disease
treatments [49,50]. Chronic inflammation that persists for a long time has a strong link with the
development of many chronic diseases including cancer, cardiovascular (CVD), neurodegenerative,
and respiratory diseases [3,51]. Moreover, there is a positive correlation between n-3 PUFA dietary
consumption and incorporation of these FA into cell membranes [52,53] that explains a positive effect
of adequate dietary n-3 PUFA consumption on inhibiting chronic diseases.
Cardiovascular diseases refer to a collective term for heart and/or blood vessels related diseases that
are by far, the most leading cause of mortality worldwide with 17.9 million deaths reported in 2018 [13].
Therefore, the effects of n-3 PUFA on major CVD including coronary heart disease (CHD) and stroke
have been reported in numerous studies [54–56]. One of the potential roles of n-3 PUFA in reducing the
risk of CHD is by counteracting many steps of atherosclerosis [57], the major cause of CHD [58]. Novel
findings [59] demonstrated that enriched-DHA canola oil supplementation could reduce the risk of
CHD by improving high-density lipoprotein cholesterol, triglycerides, and blood pressure. In addition,
previous meta-analyses established the link between increasing intakes of n-3 LC-PUFA and reducing
the risk of CHD death by 10–30% [54]. In terms of stroke, dietary consumption of n-3 PUFA can
reduce the volume of ischemic stroke [60] by promoting antioxidant enzyme activities or partly acting
as an antioxidant. n-3 PUFA can provide further benefits relating to stroke post-treatments [55],
by generating other important responses such as neuranagenesis and revascularization. The latest
meta-analysis of prospective cohort studies [61] supported a strong inverse relationship between
daily fish intake and the risk of stroke. Following CVD, cancer is the second most common cause
of death [13]. Clinical and epidemiological studies have demonstrated the role of n-3 LC-PUFA in
either reducing the risk of developing cancer or improving chemotherapy outcomes in existing cancer
patients of several common types of cancer [3,62]. Long-term studies by Kato et al. [63], Terry et al. [64]
and Takezaki et al. [65] concluded that increased consumption of dietary n-3 LC-PUFA lowered the risk
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of colorectal, prostate and lung cancer, respectively. Van Blarigan et al. [66] also reported that higher
intake of n-3 LC-PUFA improved disease-free survival by 28% in colon cancer patients. The effect of
these PUFA is more varied. While Holmes et al. [56] showed no relation between fish consumption
and breast cancer, recent studies confirmed the positive impact of n-3 fat on not only inhibiting [67,68],
but also reducing fatigue [69], in breast cancer patients. In contrast to the large number of studies
that confirmed the positive effects of n-3 PUFA on these two major chronic diseases, other research
findings reported neutral, inconclusive or even possible negative effects [62]. For instance, there was
no statistically significant association between major CVD events and n-3 PUFA supplementation
based on a meta-analysis of previous randomized clinical trials [70]. Similarly, results from a large
prospective cohort study by Rhee et al. [71] reported a neutral effect of n-3 PUFA intake on the risk of
major CVD in healthy women aged ≥45 years. With respect to cancer, Holmes et al. [72] showed that
there was no relationship between fish consumption and breast cancer, while in one case, the intake of
n-3 PUFA was claimed to induce the risk of basal cell carcinoma on skin cancer [73].
Apart from CVD and cancer, large studies have recognised the role of n-3 LC-PUFA in regards to
brain related cognitive treatments and other common chronic diseases such as rheumatoid arthritis,
type-2 diabetes and obesity. Relating to brain issues in humans, bioactivities of n-3 LC-PUFA,
particularly DHA, play an important role in neural membrane structure, neurotransmission, and signal
transduction [74], and positive effects on treatment of different neurodegenerative and neurological
disorders [75]. Lower n-3 PUFA intakes have been reported to induce the risk of Alzheimer’s
disease [76], while increased fish oil intakes for Parkinson’s disease patients resulted in a significant
reduction in depressive symptoms [77]. Examining rheumatoid arthritis, Abdulrazaq et al. [78]
reported that a majority of studies confirmed the beneficial effect of utilising n-3 LC-PUFA at doses
of 3-6 g/day on pain relief in patients. Findings on the benefits of n-3 PUFA consumption in type-2
diabetes and obesity remain inconsistent. While some authors have recognised that n-3 PUFA intake
can reduce the incidence of diabetes [79,80], the findings from a systematic review and meta-analysis
reported by Wu et al. [81] suggested a neutral effect of EPA + DHA and seafood consumption on the
development of diabetes. Similarly, no significant relationship between n-3 PUFA and obesity was
reported in the review by Albracht-Schulte et al. [82]. In contrast, high fish intake in men could lower
the risk of being overweight [83], although an opposite result was observed in women with higher fish
consumption [84].
The controversies regarding the role of n-3 PUFA in chronic diseases may be explained by many
factors such as dose, duration, baseline intake [85], specific type of the chronic disease and risk
group [86]. Due to this continuous debate and variations in experimental design, it has not been very
evident from current scientific literature and medical opinion confirming or rejecting the beneficial
effects of n-3 PUFA in reducing the risk of human chronic diseases [62]. Therefore, large and unified
clinical trials need to be conducted to conclusively identify the exact role of n-3 PUFA as independent
or supplementary factors in specific chronic diseases.
3. Lipid Metabolism in Ruminants: Obstacles to Enriching Milk Fat with n-3 PUFA
Since all of the long-chain FA in milk fat are derived from the absorption of fatty acids from the
small intestine and body fat reserves that have both originated from dietary FA [17,87], manipulating the
diet or feeding regime is the most popular way to alter milk fat composition. However, the efficiency
of this approach in ruminants is still limited due to rumen microbial fermentation [88].
Dietary lipid sources for ruminants are mainly from forages, supplements or concentrates including
cereal grains, oilseeds and animal fats. Lipids derived from forages contain largely glycolipids and
phospholipids, while triglycerides are found primarily in supplements [89]. Once dietary lipids enter
the rumen, lipolysis occurs and it involves hydrolysis of ester linkages to release free fatty acids for the
next biohydrogenation (BH) process [88] (Figure 2).
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Under the activity of rumen microbes, unsaturated fatty acids (UFA) including PUFA are
hydrogena ed to m nouns turated FA (MUFA) a d ultimately, saturated FA (SFA) through the
addition of a double bond of two hydrogen atoms. The principal role of this process is to maintain
a stable rumen environment by reducing the toxic effects of free UFA on bacterial growth in the
rumen [89]. Due to the high rate of hydrolysis and BH, only small amounts of PUFA from the diet can
pass through the rumen into the duodenum for absorption [90]. According to Shingfield et al. [91],
dietary ALA in the rumen can be hydrogenated into 18:0 (Figure 4) at the rate of 85% to 100%. Both
in vivo [92] and in vitro [93] studies have confirmed an extensive BH of dietary EPA and DHA that
was greater than 90%. In contrast to ALA, these PUFA are not completely hydrogenated into SFA,
but numerous intermediates are produced including a majority of UFA and much lesser amounts of
SFA [94]. The most recent in vitro study [95] suggests that while the reduction of the double bond
at the closest position to the carboxyl group is the main BH pathway of EPA and DPA (Figure 3),
this process is much less important for DHA. In addition, these authors stated that the possible
interspecies differences between bovine and ovine BH of n-3 LC-PUFA is directly correlated with
slower and less complete BH observed in cattle, especially for EPA and DPA. However, the specific
pathways for BH of individual n-3 LC-PUFA still remain unclear.
Apart from ruminal BH, given the relatively low absorption rate from the small intestine into the
mammary gland at 49% for ALA, and ranging from 14% to 33% for EPA, and from 13% to 25% for
DHA [17], it is not surprising that the proportion of these PUFA in dairy products is generally very
low. Principal strategies for increasing n-3 PUFA in milk and milk products, therefore, have been to
minimize the biohydrogenation effects of ruminal microbes and/or improving the absorption rate of
these FA into the mammary gland.
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4. Recent Attempts to Increase n-3 PUFA Content In Dairy-Derived Products
Up to the present time, the nutritional manipulation of feeding regimes and supplementation
with lipid sources containing high amounts of n-3 PUFA [17,96] are the major approaches to improving
n-3 PUFA content in dairy products. In contrast, current efforts to employ genetic programmes in this
theme have not yet yielded significant enhancement because the FA profile of milk processed products
primarily depends on the FA composition of raw milk [97–99]. Therefore, current studies mostly focus
on milk content as the principal route of increasing n-3 PUFA in other processed products.
4.1. Feeding Regime
Previous studies had demonstrated that feeding regime, particularly changes in forage sources
and feeding systems, had significant effects on shorter chain n-3 PUFA, but minor effects on n-3
LC-PUFA concentrations in both dairy ewes and cows (Table 3). This is because lipids from pasture
sources contain abundant amounts of ALA [100,101], but not EPA, DHA and DPA. For example, ALA
content of fresh ryegrass varieties, a popular pasture used for ruminants worldwide, ranges from 62 to
74% of total fatty acids [102]. However, the pasture conservation processes, particularly grass wilting
in the field, generally cause the oxidative loss of forage PUFA, subsequently and markedly reducing
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the content of ALA in hay or silage [100]. Wilting ryegrass 24 h in glasshouse, for instance, reduced the
percentage of ALA by 33% compared to unwilted grass [103]. Therefore, dairy ruminants that are kept
in grazing systems or have free access to fresh grass produced much higher proportions of ALA in
milk compared with animals fed conserved grass (hay and silage) [104–107]. These results appear to
be supported by the higher ALA intake of animals fed or grazed on fresh pastures.Nutrients 2019, 11, x FOR PEER REVIEW 9 of 24 
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Figure 4. Ruminal biohydrogenation of alpha-linolenic acid. Thick arrows represent the major pathway;
dotted lines with arrows represent putative pathway (adapted from Gomez-Cortes et al. [108]).
The transfer of n-3 PUFA from forage into milk and milk products is also influenced by forage
species (Table 3). Grazing dairy cows on diverse alpine pastures produced more ALA in their milk
than on ryegrass-dominated paddocks (1.15 vs. 0.70 g/100 g FA) [105]. Both Addis et al. [109] and
Bonanno et al. [110] reported the greatest concentration of ALA in sheep milk and cheese from ewes
grazed on Sulla pasture, versus other common forages including ryegrass, burr medic and daisy
forb. Guzatti et al. [111] showed higher levels of ALA in ewe milk for animals fed on clover silage
compared with lucerne silage (0.92 vs. 0.70 g/100 g FA). Disparities observed between forage species
in the transfer of n-3 PUFA into milk in these studies were not correlated with ALA intake, but were
associated with variation in condensed tannin content in the forages. The most possible mechanisms
and effects of the condensed tannins were explained by Cabiddu et al. [112], in which tannins inhibited
rumen microbial activities, thus ultimately lowering the PUFA biohydrogenation process in the rumen.
The attempt to reduce microbial species involved in biohydrogenation such as B. proteoclasticus has
been implemented with limited success due to many factors. For more details, see comprehensive
coverage by Lourenco et al. [113].
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4.2. Lipid Supplementation
Lipid supplementation has been used as an effective tool to improve animal performance due
to its significant energy contribution [101], and it can also alter milk fat composition because of the
high content of essential FA [114,115]. Fish oils and marine products, oilseeds and vegetable oils are
the main sources that have been employed in ruminant diets to enhance the concentrations of health
beneficial n-3 PUFA and n-3 LC-PUFA in milk and milk products [101].
4.2.1. Oil Seed and Vegetable Oil
Plant-derived fat is the most common fat source in ruminant supplements, and includes both
oilseeds and extracted vegetable oils. This is because these materials not only contain a high
concentration of PUFA [116], protein and energy [117], but are also more readily available and cheaper
than other (marine) sources [22]. Therefore, a number of studies have examined the effects of oilseed
and vegetable oils on the concentration of health beneficial n-3 PUFA in both bovine and ovine
milk products (Table 4). Based on previously reported results, the addition of flaxseed or linseed
supplements in ruminant diets is a more effective strategy to enrich milk n-3 PUFA compared to other
plant fat supplementation methods (Table 4). Due to its very high content in ALA at approximately
53% of all FA [118], cows or sheep supplemented with flaxseed had substantial enhancement of this
shorter chain n-3 PUFA in milk products (Table 4).
Table 3. Effect of pasture feeding regimes on n-3 PUFA content of milk (g/100 g fatty acids).
Forage Source/Feeding System Species ALA EPA DHA DPA References
Ryegrass-dominated pastures Bovine 0.703 0.083 0.009 0.109 Leiber et al. [105]
Freshly harvested ryegrass 0.619 0.073 0.009 0.113
Alpine pastures 1.146 0.083 0.009 0.120
Freshly harvested Alpine 0.950 0.083 0.010 0.118
Silage-concentrate diet (control) 1 0.516 0.063 ND 0.082
Ryegrass pasture Bovine 0.68 0.05 0.02 0.07 Mohammed et al. [107]
Freshly harvested ryegrass 0.82 0.07 0.02 0.08
Ryegrass silage 0.34 0.05 0.02 0.09
Indoor hay based diet Bovine 0.72 0.08 - 0.147 Coppa et al. [119]
Rotational grazing system 0.727 0.070 - 0.137
Continuous grazing system 0.940 0.087 - 0.150
Indoor conventional system Bovine 0.579 0.072 - 0.118 Stergiadis et al. [120]
Indoor organic system 1.199 0.098 - 0.098
Mixed forage 2 Bovine 0.47 - - - Liu et al. [121]
Corn stalk1 diet (35%) 0.58 - - -
Corn stalk2 diet (53.8%) 0.63 - - -
Daisy forb − winter Ovine 1.62 - - - Addis et al. [109]
Ryegrass − winter 1.47 - - -
Burr medic − winter 2.19 - - -
Sulla − winter 2.98 - - -
Daisy forb − spring 1.26 - - -
Ryegrass − spring 1.44 - - -
Burr medic − spring 1.84 - - -
Sulla − spring 3.15 - - -
Pasture Ovine 1.07 0.06 - 0.13 Gomez-Cortes et al. [104]
Pasture + oat grain 0.59 0.05 - 0.12
Total mixed ration 3 0.33 0.03 - 0.06
Grass hay (in door) Ovine 1.31 0.19 0.30 - Mierlita [106]
Part-time grazing 2.06 0.28 0.39 -
Pasture Ovine 2.09 0.30 0.37 - Mierlita et al. [122]
Pasture + standard concentrate 3 1.04 0.11 0.18 -
Pasture Ovine 0.44 0.01 0.07 0.13 Mohamed et al. [123]
Pasture + concentrate 0.24 0.00 0.12 0.07
Concentrate 0.21 0.00 0.00 0.08
Red clover silage Ovine 0.92 0.05 - 0.09 Guzatti et al. [111]
Lucerne silage 0.70 0.05 - 0.09
1 The control diet contained 60% ryegrass silage, 30% maize silage and 10% grass hay on dry matter basis. 2 Mixed
forage contained 26.7% corn silage, 23.4% alfalfa hay and 3.7% Chinese wild rye on dry matter basis. 3 Total mixed
ration contained concentrate and forage in proportion of 80:20.
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Oil infusion is also considered an effective form of providing plant oil supplements that increases
the escape rate of UFA from the BH of rumen microbes, thus enhancing the availability of n-3 PUFA
for absorption [17]. Khas et al. [124] reported that adding 160 g/day of infused free ALA in the diet for
lactating cows increased ALA content in milk by 41-fold, and also resulted in significant increases in
milk EPA and DPA by two-fold and three-fold, respectively. However, supplementation with vegetable
seed and oils only marginally increased milk EPA, DHA, and DPA in both bovines and ovines, with the
percentages of these FA often lower than 0.1 g/100g FA (Table 4). These findings indicated that the
endogenous biosynthesis pathway of these n-3 LC-PUFA from dietary ALA in dairy animals is limited.
4.2.2. Marine Lipid Sources
Feeding dairy animals with marine oil resulted in the highest n-3 LC-PUFA concentration in milk
and milk products (Table 5) among all types of lipid supplements examined. Previous studies also
confirmed the efficiency of utilising rumen-protected forms of marine products that were markedly
higher than in the untreated controls; mainly as a result of the lesser extent of ruminal biohydrogenation
with the rumen-protected diets [125]. Kitessa et al. reported that the content of EPA and DHA, which
are generally scanty in milk (Tables 3 and 4), could be increased by supplementing both dairy cattle [126]
and ewes [127] with rumen-protected fish oil. The proportion of DHA, the most essential n-3 LC-PUFA,
observed in these studies, exceeded 1% of the total FA. Similarly, an effective incorporation rate of DHA
from a marine algae supplement, an alternative to fish oil into milk, was also confirmed by a number of
studies (Table 5). This transfer rate appears to be higher as observed in ovine [128] than in bovine [129].
Results presented in Table 5 also indicate that supplementing fish oil is more advantageous than marine
algae in terms of improving milk EPA and DPA content.
Recent focus on achieving quantitatively significant amounts of n-3 PUFA per standard serve
of milk and milk products has occurred [45,46]. This absolute FA concentration data may be more
accurate than the proportion (expressed as %FA) itself, since the fat percentage of milk from different
species varies widely [130], and such quantitative data can potentially assist consumers in purchasing
decisions. One serve of fresh milk produced from grazing ewes supplemented with rumen-protected
EPA + DHA contains 62 mg of total n-3 LC-PUFA, three-fold higher than the control group [45]. This
result is higher than the concentration of total EPA + DHA + DPA in one serve of cooked lamb meat
(55 mg) reported by Flakemore et al. [131]. In achieving 60 mg/serving, this sheep milk can also be
considered as achieving a “good source” level of n-3 LC-PUFA, adhering to Food Standards Australia
and New Zealand (FSANZ) [132]. Although the inclusion of fish oil into ruminant diets might have a
negative effect on meat quality such as possible rancidity and abnormal flavour in cooked or grilled
lamb [133], no side effects on milk and milk products have been reported. Nguyen et al. [46] observed
no differences in sensory eating traits between ripened cheese processed from milk produced by dairy
sheep supplemented with rumen-protected marine source and the unsupplemented group. However,
the higher cost of the marine oil source possibly limits its utilization as a routine supplementation for
dairy ruminants [101].
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Table 4. Effect of supplementing ruminants with plant-derived dietary sources on n-3 PUFA
concentration in milk and milk products (g/100 g fatty acids).
Diet Species Product ALA EPA DHA DPA References
Control
Bovine Milk
0.61 0.09 - 0.07
Khas et al. [124]
40 g/day infused LNA-rich fatty acid 6.49 0.18 - 0.12
80 g/day infused LNA-rich fatty acid 12.42 0.22 - 0.16
120 g/day infused LNA-rich fatty acid 18.75 0.21 - 0.29
160 g/day infused LNA-rich fatty acid 25.38 0.22 - 0.23
Control
Bovine Milk
0.75 0.003 0.001 - Caroprese et al. [134]
Whole flaxseed 0.81 0.022 0.001 -
Control
Bovine Milk
0.41 0.05 - 0.05
Dai et al. [135]Rapeseed oil 0.38 0.06 - 0.04
Peanut oil 0.33 0.06 - 0.06
Sunflower seed oil 0.32 0.06 - 0.05
Control
Bovine Milk
0.83 0.09 0.01 0.13
Otto et al. [136]25mL/kg DM
1 Canola oil 0.85 0.09 0.01 0.14
35 mL/kg DM canola oil 0.95 0.08 0.01 0.12
50 mL/kg DM canola oil 0.97 0.08 0.00 0.11
Control
Bovine Milk
0.28 0.02 - -
Cattani et al. [137]500 g/day extruded flaxseed 0.50 0.02 - -
1000 g/day extruded flaxseed 0.59 0.02 - -
Linseed oil
Bovine Milk
0.249 0.019 - 0.014 Li et al. [138]
Safflower oil 0.180 0.013 - 0.007
Control
Bovine Milk
0.19 0.012 0.004 0.037
Welter et al. [139]3% Canola oil 0.36 0.011 0.003 0.034
6% Canola oil 0.35 0.011 0.003 0.033
Control
Bovine Milk
0.19 - 0.019 - Vanbergue et al. [140]
Extruded linseed 0.51 - 0.008 -
Palm oil
Ovine Milk
0.52 0.04 0.02 0.08
Bodas et al. [141]Olive oil 0.36 0.03 0.02 0.06
Soybean oil 0.53 0.03 0.02 0.07
Linseed oil 1.07 0.05 0.04 0.11
Control
Ovine Milk
1.21 0.05 0.05 -
Mughetti et al. [142]100 g extruded linseed 1.65 0.06 0.09 -
200 g extruded linseed 2.26 0.06 0.10 -
Control
Ovine Milk
0.57 0.07 0.05 0.08
Caroprese et al. [143]Seaweed 0.59 0.06 0.04 0.08
Whole flaxseed 1.53 0.08 0.05 0.09
Seaweed + Whole flaxseed 1.32 0.08 0.06 0.10
Control
Ovine Milk
0.62 0.08 0.04 0.08
Nguyen et al. [45]
Canola oil 0.73 0.09 0.06 0.13
Rice bran oil 0.51 0.07 0.04 0.10
Flaxseed oil 1.74 0.11 0.06 0.15
Safflower oil 0.67 0.07 0.06 0.10
Control
Ovine Milk
0.31 0.04 0.02 0.08
Parentet et al. [144]Canola oil 0.26 0.03 0.02 0.07
Sunflower oil 0.24 0.03 0.02 0.07
Castor oil 0.28 0.05 0.01 0.08
Control
Bovine Cheese
0.29 0.02 - -
Cattani et al. [137]500 g/day extruded Flaxseed at 0.50 0.02 - -
1000 g/day extruded Flaxseed at 0.61 0.02 - -
Palm oil
Ovine Cheese
0.54 0.04 0.02 0.07
Bodas et al. [141]Olive oil 0.36 0.03 0.03 0.06
Soybean oil 0.51 0.03 0.02 0.06
Linseed oil 1.04 0.03 0.03 0.09
Control
Ovine Cheese
1.18 0.02 0.03 -
Mughettiet al. [142]100 g extruded linseed 1.84 0.04 0.05 -
200 g extruded linseed 2.02 0.04 0.06 -
Control
Ovine Cheese
0.71 0.11 0.06 0.12
Nguyen et al. [46]
Canola oil 0.79 0.11 0.06 0.13
Rice bran oil 0.63 0.10 0.06 0.12
Flaxseed oil 1.30 0.11 0.06 0.13
Safflower oil 0.71 0.11 0.08 0.13
Control
Ovine Yogurt
0.0 - - -
Bianchi et al. [145]2% Palm oil 0.0 - - -
4% Palm oil 0.28 - - -
6% Palm oil 0.31 - - -
1 DM: dry matter.
4.3. Genetic Manipulation as a Potential Tool for the Enrichment of Dairy Products with n-3 PUFA
Attempts at understanding and estimating genetic parameters influencing milk FA content
that may be beneficial for human health had been made a decade ago [146,147]. Up to the present
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time, low heritabilities (<0.1) for individual n-3 PUFA (Table 6) were consistently reported in dairy
cows [147–149] and dairy sheep [150], indicating a low impact of genetics or breed on the concentration
of n-3 PUFA. This observation probably arises because the fatty acids longer than 18 carbon chains are
not de novo synthesized in the mammary gland, but are circulated from the blood which contains
lipids that originated from the diet [94]. Moderate heritabilities for the whole group of n-3 PUFA were
reported by Boichard et al. [151] and Maroteau et al. [152], and could be explained by major contribution
of the shorter chain n-3 PUFA. First identified in the human genome in 2000 [153], fatty acid desaturase
1 and 2 (FADS1 and FADS2) are considered as the major candidate genes that regulate the endogenous
synthesis of n-3 LC-PUFA from ALA in mammals including ruminants [154–158]. The first effort
to define the association between these two encoding genes and n-3 PUFA in the milk of Holstein
cows [159] found that three significant single nucleotide polymorphism (SNP) markers within FADS1
and FADS2 were associated with EPA. Apart from the two well-characterized FADS1 and FADS2 genes,
Ibeagha-Awemu et al. [160] uncovered more potential candidate genes with several novel SNPs that
were significantly associated with milk EPA and DPA. Consequently, by employing these potential
genetic markers, future research can investigate the specific relationships between combining genetics
and other environmental strategies such as nutritional supplementation for elevating n-3 LC PUFA
in milk.
Table 5. Effect of supplementing ruminants with dietary marine sources on n-3 PUFA concentration of
milk and milk products (g/100 g fatty acids).
Diet Species Product ALA EPA DHA DPA References
Control
Bovine Milk
0.54 - 0.00 -
Franklin et al. [161]Protected algae 0.49 - 0.76 -
Unprotected algae 0.47 - 0.46 -
Control
Bovine Milk
0.86 0.0 0.0 - Kitessa et al. [126]
Rumen-protected tuna oil 1.28 0.61 1.09 -
Control
Bovine Milk
0.21 0.03 0.00 0.07 Shingfield et al. [162]
Fish oil and sunflower oil 0.23 0.11 0.07 0.16
Control
Bovine Milk
0.50 - 0.09 - Boeckaert et al. [129]
Marine algae 0.42 - 1.01 -
ABO/ABO 1
Bovine Milk
14.4 0.22 - 0.22
Kazama et al. [163]RUM/ABO
2 4.78 0.14 - 0.22
RUM/RUM 3 2.33 0.09 - 0.12
ABO/RUM 4 11.6 0.16 - 0.18
Control
Bovine Milk
0.75 0.003 0.001 - Caroprese et al. [134]
Fish oil 0.84 0.060 0.117 -
Control
Bovine Milk
0.45 0.06 0.10 -
Vargas-Bello-Pérez et al. [164]Fish oil 0.62 0.10 0.21 -
Fish oil + palm oil 0.69 0.09 0.14 -
Control
Bovine Milk
0.41 0.06 0.03 0.09
Kairenius et al. [165]Ultrarefined fish oil at 75 g/day 0.38 0.06 0.03 0.08
Ultrarefined fish oil at 150 g/day 0.39 0.07 0.05 0.10
Ultrarefined fish oil at 300 g/day 0.48 0.17 0.10 0.18
Control
Bovine Milk
0.19 - 0.019 -
Vanbergue et al. [140]Microalgae DHA Gold® 0.25 - 0.444 -
Extruded linseed + DHA Gold® 0.46 - 0.170 -
Control
Ovine Milk
0.33 ND ND ND
Papadopoulos et al. [128]Low algae (23.5 g) 0.31 0.04 0.43 0.21
Medium algae (47 g) 0.33 0.12 0.69 0.28
High algae (94 g) 0.25 0.21 1.24 0.31
Control
Ovine Milk
0.53 0.05 0.03 0.10
Toral et al. [166]
Sunflower oil (SO) 0.41 0.04 0.02 0.07
SO + 8 g/kg DM of Marine Algae 0.37 0.05 0.17 0.10
SO + 16 g/kg DM of Marine Algae 0.36 0.09 0.46 0.13
SO + 24 g/kg DM of Marine Algae 0.34 0.10 0.57 0.15
Sunflower oil
Ovine Milk
0.49 0.04 0.05 0.10 Bichi et al. [167]
Sunflower oil + Marine algae 0.48 0.06 0.38 0.12
Control
Ovine Milk
0.62 0.08 0.04 0.08 Nguyen et al. [45]
Rumen-protected EPA + DHA oil 0.74 0.17 0.19 0.23
Control
Bovine Cheese
0.01 0.05 0.09 -
Vargas-Bello-Pérez et al. [164]Fish oil 0.02 0.12 0.34 -
Fish oil + palm oil 0.01 0.09 0.18 -
Control
Ovine Cheese
0.71 0.11 0.06 0.12 Nguyen et al. [46]
Rumen-protected EPA + DHA 1.02 0.16 0.15 0.19
1 ABO/ABO diet contains abomasal flax oil and hulls infusion. 2 RUM/ABO diet contains flax oil placed in the rumen
and hulls infused in the abomasum. 3 RUM/RUM diet contains flax oil and hulls placed in the rumen and abomasal
infusion of water. 4 ABO/RUM diet contains flax hulls administered in the rumen and abomasal flax oil infusion.
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Table 6. Heritability estimates of major individual and group of n-3 fatty acids.
Breed Species Unit ALA EPA DPA n-3 Reference
Holstein-Friesians Bovine %FA 0.09 - - - Stoop et al. [147]
Holsteins Bovine % FA 0.06 0.04 0.01 - Bilal et al. [148]
Brown Swiss Bovine % FA 0.093 0.045 0.039 0.085 Pegolo et al. [149]
Sarda Ovine % FA 0.02 - - - Correddu et al. [150]
Holstein Bovine
% fat
- - - 0.26
Boichard et al. [151]Saanen Caprine - - - 0.23
Lacaune Ovine - - - 0.18
Alpine Caprine
% fat
- - - 0.28 Maroteau et al. [152]
Saanen Caprine - - - 0.25
5. Conclusions
Since first being reported some four decades ago, the number of studies confirming the beneficial
effects of n-3 PUFA on reducing the risk of chronic diseases including cardiovascular disease, cancer,
mental illnesses, age-related cognitive decline, and inflammatory diseases were over and above those
that found neutral or adverse effects. Specific mechanisms with respect to the independent and/or
supplementary influences of n-3 PUFA on human health, however, remain controversial and need
further investigations. Consumption of seafood as the major source of n-3 LC-PUFA is still generally
insufficient, resulting in the need for enhancing the concentration of these beneficial n-3 LC-PUFA
in other common dietary sources for human consumption. Attempts to increase the content of n-3
LC-PUFA in milk and milk products, which are important components of the human diet, has therefore
been a major research focus for the last two decades. Current studies generally demonstrate that
the processes of lipolysis combined with dietary lipid BH in the rumen are the main obstacles in
modulating n-3 LC-PUFA content of dairy products. In addition, the biosynthetic pathway of these
FA from the precursor ALA, is limited, with only minor conversion occurring. Thus, supplementing
ruminants with marine-derived sources in a rumen-protected form is at this time, one of the best
strategies to increase n-3 LC-PUFA content in milk and its processed products. Yet, there seems
to be a lack of evaluation regarding the economic efficiency of different supplemented ingredients
utilized in the current research. We propose that further studies are required to better elucidate the
n-3 LC-PUFA biosynthesis pathway from ALA, together with the BH mechanism of individual n-3
LC-PUFA. A more comprehensive knowledge of these aspects would be a guiding principle for further
research on increasing the escape rate of dietary PUFA from the rumen and their absorption rate from
the small intestine into milk. Genetically modifying oilseeds as an alternative and sustainable source
of dietary n-3 LC-PUFA for ruminants should be taken into account when future supplies of fish oil
may not be sufficient. Finally, activities of regulated genes on the concentration of n-3 PUFA and their
reaction to non-genetic factors such as lipid supplementation for specific dairy species also needs to be
better defined. Identified knowledge gaps regarding the activities of candidate genes regulating the
concentrations of n-3 PUFA and the responses of ruminants to specific lipid supplementation regimes
are also critical to a greater understanding of nutrition-genetics interactions driving lipid metabolism.
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